Miguel Cordova-Delgado

10PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersHaematological tumoursLiquid biopsiesCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 27, 2026
Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With Cancer.

Edward J Raack, Wan-Chun Chang, Miguel Cordova-Delgado

|Jul 25, 2025
Four Pharmacogenomic Variants Strongly Linked to Corticosteroid-Induced Avascular Necrosis in Children with Cancer.

Miguel Cordova-Delgado, Erika N Scott, Shahrad R Rassekh

|Mar 22, 2025
Amino Acid Stress Response Genes Contribute to a 25-Fold Increased Risk of L-Asparaginase-Induced Hypersensitivity.

Spencer J Anderson, Erika N Scott, Edward J Raack

|Apr 27, 2024
Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population.

Gareth I Owen, Miguel Cordova-Delgado, Bernabé I Bustos

|Jan 08, 2023
Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients.

Mauricio P Pinto, Matías Muñoz-Medel, Ignacio N Retamal

|Feb 25, 2022
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience.

Miguel Cordova-Delgado, Mauricio P Pinto, Carlos Regonesi

Pageof 2

Frequent Collaborators

5 joint publications

Gareth I Owen

4 joint publications

Mauricio P Pinto

3 joint publications

Ignacio N Retamal

2 joint publications

Hector Galindo